Old Web
English
Sign In
Acemap
>
authorDetail
>
Chay Ngee Lim
Chay Ngee Lim
Pfizer
Focal segmental glomerulosclerosis
Proteinuria
Medicine
Urology
Clinical endpoint
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis
2021
Kidney International Reports
Laurence H. Beck
Stephen P. Berasi
J. Brian Copley
Donal Gorman
Daniel I. Levy
Chay Ngee Lim
Joel M. Henderson
David J. Salant
Weining Lu
Show All
Source
Cite
Save
Citations (0)
A Phase 1 first-in-human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF-06730512 in healthy participants.
2021
Pharmacology Research & Perspectives
Chay Ngee Lim
Constantino Kantaridis
Isabelle Huyghe
Donal Gorman
Stephen P. Berasi
Gabriele E. Sonnenberg
Show All
Source
Cite
Save
Citations (0)
1